A nemia is a common condition among communitydwelling older adults, with prevalence estimates ranging from 9-18% in men and 8-13% in women.1 In those aged 85 years and older -a rapidly growing segment of the world's population -the prevalence of anemia exceeds 20%.2 Importantly, however, less than 1% of community-dwelling older adults have a hemoglobin concentration below 10 g/dL and, therefore, the majority of cases of anemia are mild.2 In contrast, anemia is more severe in institutionalized settings, such as nursing homes, in which the prevalence of anemia ranges from 48-63% in older residents.1 Nonetheless, numerous studies over the past decade have shown that anemia is an independent predictor of a variety of adverse outcomes in both community-dwelling and institutionalized older adults. While evidence continues to accrue suggesting that anemia initiates or exacerbates functional decline, it remains unresolved whether anemia is a marker or a cause of poor prognosis in older adults.
Mortality and hospitalizationMortality risk is significantly higher in older anemic adults than in the non-anemic elderly. This association was observed in several major cohort studies and remains significant even after excluding older adults with comorbid conditions (e.g., cardiovascular disease, cancer, kidney disease).3-5 Low-normal hemoglobin concentrations have also been shown to be associated with increased mortality, 5-8 although this finding is not consistent across studies and depends on the definition of low-normal and the comparison group as well as race/ethnicity and comorbidity. 4,9,10 It has been suggested that anemia might be masked in some older adults taking diuretics, which can decrease plasma volume, potentially explaining the low-normal hemoglobin concentration to mortality association.
11Alternatively, it is probable that some older adults with low-normal hemoglobin concentrations are more likely to eventually go on to become anemic, potentially increasing their risk of adverse events. Indeed, a recent study of heart failure patients showed that those who had persistent anemia or developed new onset anemia over a 6-month period were more likely to die than patients who remained non-anemic.12 Importantly, patients whose anemia resolved within 6 months did not have increased mortality, but it was unclear what role treatment played in the resolution of anemia.
12In this issue of the journal, Riva and colleagues reported the risk of hospitalization and death by anemia status in Italian adults aged 65-84 living in Biella, Piedmont.13 These investigators were particularly interested in the effects of mild anemia, defined as a hemoglobin concentration between 10.0 and 11.9 g/dL in women and 10.0 and 12.9 g/dL in men. Consistent with other population-based studies, less than 1% (31/4,501) of the study participants had a hemoglobin concentration below 10 g/dL. After adjusting for potential confounding factors, over the 3-3.5 year follow-up period there was a 32% increased risk of hospitalization and a nearly two-fold i...